Composition with repairing and anti-aging effects and application thereof

By rationally combining recombinant type I and type III humanized collagen and adding fibronectin and type XVII collagen, this product addresses skin laxity and aging caused by collagen loss, providing firming, moisturizing, and soothing repair effects. It is suitable for cosmetics, especially for sensitive skin.

CN118902905APending Publication Date: 2024-11-08ZHEJIANG ZHUJI JUYUAN BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410951873.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-16
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Existing technologies are insufficient to effectively address skin laxity and aging caused by collagen loss, especially for repairing and anti-aging sensitive skin.

Method used

It employs a rational combination of recombinant type I and type III humanized collagen in a ratio of 1:4, and may optionally add recombinant fibronectin and type XVII collagen to form a synergistic composition for use in cosmetics. Combining the principles of skin bionics, it provides skin firming and soothing repair effects.

Benefits of technology

It achieves skin firming, moisturizing, and soothing repair, enhances the skin barrier function, is suitable for sensitive skin, improves anti-aging performance, and does not cause irritation to the human body.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118902905A_ABST
    Figure CN118902905A_ABST
Patent Text Reader

Abstract

The invention discloses a composition with repairing and anti-aging effects and application thereof. The composition comprises a recombinant I type humanized collagen and a recombinant III type humanized collagen, and can also comprise a recombinant fibronectin and a recombinant XVII type collagen. According to the invention, skin biomimetic biology is utilized to scientifically simulate the combination proportion of infant collagen, according to the collagen loss proportion, the ratio of recombinant I-type collagen to recombinant III-type collagen is approximately equal to 1: 4, the recombinant I-type collagen and the recombinant III-type collagen act synergistically to reach the skin state in the infant period, and recombinant fibronectin and recombinant XVII-type collagen are further added and are synergistically matched, so that the skin can be more compact, and the skin can be more comfortable. The repairing effect and the anti-aging performance are further improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of cosmetics and relates to a composition with repairing and anti-aging effects and application thereof. Background Art

[0002] Collagen is the main structural protein in the extracellular matrix of animals with multiple biological functions. It is widely present in human skin, bones, muscles and other tissues. It participates in cell proliferation, differentiation, migration and signal transmission, and plays a supporting, repairing and protective role. Collagen is an important component of human skin, mainly type I and type III. Type I collagen, as the main component of adult skin (accounting for about 80%), can support the dermis and epidermis of the skin, so that the skin maintains its contour and is resilient. Type III collagen is distributed in a reticular manner around type I collagen, which is used to support the tenderness of the skin, making the skin delicate and elastic, and has excellent elasticity and repair functions. As people age, more and more collagen is lost, and the ability of fibroblasts in the body to synthesize collagen gradually decreases, so that the synthesis of collagen in the skin cannot keep up with the loss, the skin gradually becomes loose, and various aging phenomena such as sensitivity and wrinkles appear. Summary of the invention

[0003] The purpose of the present invention is to provide a composition with repairing and anti-aging effects and its application, which is suitable for people with sensitive skin.

[0004] The technical solution for achieving the purpose of the present invention is as follows:

[0005] The composition with repairing and anti-aging effects comprises recombinant humanized type I collagen and recombinant humanized type III collagen.

[0006] Preferably, in the composition with repairing and anti-aging effects, the mass ratio of recombinant type I humanized collagen to recombinant type III humanized collagen is 4:1.

[0007] Furthermore, the composition with repairing and anti-aging effects also contains one or more of recombinant fibronectin and recombinant type XVII collagen.

[0008] Preferably, the composition with repairing and anti-aging effects comprises 0.01 to 0.1 parts by weight of recombinant fibronectin.

[0009] Preferably, the composition with repairing and anti-aging effects comprises 0.01 to 0.1 parts by weight of recombinant type XVII collagen.

[0010] Preferably, the composition with repairing and anti-aging effects is composed, by weight, of 4 parts of recombinant humanized type I collagen, 1 part of recombinant humanized type III collagen, 0.01-0.1 parts of recombinant fibronectin, and 0.01-0.1 parts of recombinant type XVII collagen.

[0011] The present invention provides application of the above-mentioned composition with repairing and anti-aging effects in preparing cosmetic raw materials or cosmetics.

[0012] Preferably, the cosmetic raw material or cosmetic is an aqueous solution, emulsion, spray, cream, gel or facial mask.

[0013] Preferably, the mass percentage of the composition with repairing and anti-aging effects in the cosmetic raw materials or cosmetics is 0.0001-1%.

[0014] Preferably, the cosmetic raw material or cosmetic comprises the above-mentioned composition with repairing and anti-aging effects and an excipient.

[0015] Preferably, the excipients can be liquid excipients or solid excipients, such as binders, fillers, disintegrants, lubricants in tablets; matrix parts in semisolid preparations such as ointments and creams; liquid preparations such as preservatives, antioxidants, flavoring agents, fragrances, cosolvents, emulsifiers, solubilizers, osmotic pressure regulators, colorants, etc. in cosmetics can all be called excipients.

[0016] The present invention provides a repair patch, the formula of which is as follows:

[0017]

[0018] Furthermore, the present invention provides a method for preparing the above-mentioned repair patch, and the specific steps are as follows:

[0019] (1) According to the formula, the moisturizer, thickener, and the composition with repair and anti-aging effects are mixed and deionized water is added, and stirred in a water bath at 80±5°C until the materials are completely dissolved;

[0020] (2) After cooling to room temperature, add a pH adjuster to adjust the pH to 6.0-8.0;

[0021] (3) folding the membrane cloth and placing it in an aluminum foil flat bag, filling the solution obtained in step (2) into the aluminum foil bag, and heat-sealing it;

[0022] (4) The aluminum foil bag was sterilized by wet heat sterilization at 110°C for 30 min to prepare a repair patch.

[0023] Compared with the prior art, the present invention has the following advantages:

[0024] (1) The present invention will utilize skin bionic biology to scientifically simulate the combination ratio of infant collagen. According to the collagen loss ratio, recombinant type I humanized collagen and recombinant type III humanized collagen are rationally matched, recombinant type I collagen: recombinant type III collagen≈1:4. The two have a synergistic effect. The combination of the two components can not only tighten the skin, nourish and moisturize, but also have the effect of soothing and repairing. It can regulate and soothe skin discomfort symptoms by strengthening the skin barrier function, repairing the keratin barrier, and relieving inflammatory reactions, thereby maintaining the skin in a stable and healthy state.

[0025] (2) The present invention further adds recombinant fibronectin and recombinant type XVII collagen on the basis of recombinant humanized type I collagen and recombinant humanized type III collagen. Through synergistic combination, the composition has good compatibility and will not cause irritation to the human body. The formula does not contain preservatives and is suitable for sensitive skin. It can make the skin firmer and further improve the repair effect and anti-aging performance. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] Figure 1 This is the result of immunofluorescence staining of filaggrin, where green fluorescence represents FLG and blue fluorescence represents cell nuclei. DETAILED DESCRIPTION

[0027] The present invention is further described in detail below with reference to specific embodiments.

[0028] In the present invention, the recombinant humanized type III collagen used is produced by fermentation of Pichia pastoris with a deposit number of CGMCC No.5021, which has been fully disclosed in Chinese patent ZL 201110327865.5; the recombinant humanized type I collagen is produced by fermentation of Pichia pastoris with a deposit number of CGMCC No.16461, which has been fully disclosed in Chinese patent ZL 201811589560.X; the recombinant fibronectin has been fully disclosed in Chinese patent application 202211088313.8; the recombinant type XVII collagen has been fully disclosed in Chinese patent application 202310618698.2.

[0029] Example 1

[0030] The composition with repairing and anti-aging effects consists of 0.01 parts of recombinant type I humanized collagen and 0.01 parts of recombinant type III humanized collagen by weight.

[0031] Example 2

[0032] The composition with repairing and anti-aging effects consists of 5 parts of recombinant type I humanized collagen and 0.5 parts of recombinant type III humanized collagen by weight.

[0033] Example 3

[0034] The composition with repairing and anti-aging effects consists of 1 part of recombinant type I humanized collagen and 2 parts of recombinant type III humanized collagen by weight.

[0035] Example 4

[0036] The composition with repairing and anti-aging effects consists of 5 parts of recombinant type I humanized collagen and 2 parts of recombinant type III humanized collagen by weight.

[0037] Example 5

[0038] The composition with repairing and anti-aging effects consists of 4 parts of recombinant type I humanized collagen and 1 part of recombinant type III humanized collagen by weight.

[0039] Comparative Example 1

[0040] This comparative example is substantially the same as Example 5, except that 0.5 parts of recombinant fibronectin is further added.

[0041] Comparative Example 2

[0042] This comparative example is substantially the same as Example 5, except that 0.5 parts of recombinant type XVII collagen is further added.

[0043] Comparative Example 3

[0044] This comparative example is substantially the same as Example 5, except that 0.1 parts of recombinant fibronectin and 0.1 parts of recombinant type XVII collagen are further added.

[0045] Comparative Example 4

[0046] This comparative example is substantially the same as Example 5, except that 0.01 parts of recombinant fibronectin and 0.01 parts of recombinant type XVII collagen are further added.

[0047] Comparative Example 5

[0048] This comparative example is substantially the same as Example 5, except that 0.5 parts of recombinant fibronectin and 0.5 parts of recombinant type XVII collagen are further added.

[0049] Performance Test 1

[0050] The compositions of Examples 1-5 and Comparative Examples 1-5 were dissolved in purified water to a concentration of 0.1% by mass and set aside. L929 cells in the logarithmic growth phase were taken and digested with trypsin. The cell suspension was centrifuged (1000 rpm, 5 min) and the original culture was discarded. The suspension was then resuspended in the culture medium to obtain 1×10 5 / mL cell suspension. The suspended cells were inoculated into a 96-well plate with 100μl per well and cultured in a cell culture incubator (37°C, 5% CO2) for 24 hours. The cell morphology was observed under a microscope. After the cells grew to form a monolayer, the original culture medium in the 96-well plate was discarded. 100μl of the composition sample was added to the corresponding wells of the 96-well plate, and a blank control sample and a positive control sample (1% ZDEC was added) were set up. The 96-well plate was placed in a cell culture incubator (37°C, 5% CO2) and cultured for 24 hours. There were 5 replicate wells in each group, and the average cell survival rate was calculated. After 24 hours of culture, the 96-well plate was taken out, the cell morphology was observed under a microscope, and then the liquid was removed, 50ul MTT (1mg / ml) was added to each well, and the cells were cultured in a carbon dioxide incubator. After 2 hours, the supernatant was removed, 100ul DMSO was added to each well to dissolve the crystals, and the absorbance value at a wavelength of 570nm was measured on an enzyme reader to calculate its cytotoxicity. The results are shown in Table 1. The compositions of Examples 1-5 and Comparative Examples 1-5 were non-cytotoxic at a mass concentration of 0.1%.

[0051]

[0052] Where:

[0053] OD 570e —The average optical density of the 100% dilution of the test sample;

[0054] OD 570b —Average value of blank optical density.

[0055] Table 1 Cellular activity of the compositions of Examples 1-5 and Comparative Examples 1-5

[0056]

[0057]

[0058] Performance Test 2

[0059] Filaggrin (FLG) is an important component of the stratum corneum, synthesized by keratinocytes and distributed in different parts of the stratum corneum. FLG dissociates from keratin and is decomposed into free amino acids, including lactic acid, urocanic acid and pyrrolidone carboxylic acid, etc., which are important components of natural moisturizing factors. Natural moisturizing factors play an important role in moisturizing and barrier integrity. The present invention evaluates the efficacy of the composition in long-term moisturizing and barrier repair by testing the relative improvement rate of the composition on filaggrin.

[0060] Cell seeding: 1×10 5 Inoculate cells into 24-well plates at a seeding density of 100 / well and incubate overnight in an incubator (37°C, 5% CO2). Prepare the solution: Use HaCaT cell culture solution and purified water to dissolve Example 1, Example 5, and Comparative Examples 3-5 to a mass concentration of 0.1% to prepare the sample working solution of the experimental group. Dosing: According to the experimental design table, when the cell plating rate in the 24-well plate reaches 40% to 60%, the original cell culture solution is sucked clean and then the group dosing is performed. In the experimental group, 1.0 mL of sample working solution was added to each well, and 3 replicates were set for each group of working solution. In the blank control group (BC group), 1.0 mL of cell culture solution was added to each well, and 3 replicates were set. In the positive control group (PC group), 1.0 mL of culture solution containing 5 μM WY14643 was added to each well, and 3 replicates were set. Place in an incubator (37°C, 5% CO2) and continue to culture for 24 hours. Sample collection: Discard the supernatant and rinse the cells 3 times with PBS. Immunofluorescence staining: Perform conventional immunofluorescence staining. The main steps are: fixation, blocking, adding primary antibody, adding secondary antibody, DAPI counterstaining, and then taking pictures using a fluorescence microscope. Use Image Pro Plus software to quantitatively analyze the FLG fluorescence intensity. The results are as follows: Figure 1 And as shown in Table 2.

[0061] Table 2 Summary of FLG content results

[0062]

[0063]

[0064] The results showed that Example 5 and Comparative Examples 3-5 could increase the expression of FLG, among which Example 5 and Comparative Example 3 had better effects.

Claims

1. A composition with repairing and anti-aging effects, characterized in that: Contains recombinant humanized type I collagen and recombinant humanized type III collagen.

2. The composition according to claim 1, characterized in that The mass ratio of recombinant type I humanized collagen to recombinant type III humanized collagen is 4:1 by weight.

3. The composition according to claim 1, characterized in that It also contains one or more of recombinant fibronectin and recombinant type XVII collagen.

4. The composition according to claim 3, characterized in that The invention also contains 0.01-0.1 parts of recombinant fibronectin or 0.01-0.1 parts of recombinant type XVII collagen by weight.

5. The composition according to claim 3, characterized in that The composition is composed of 4 parts of recombinant humanized type I collagen, 1 part of recombinant humanized type III collagen, 0.01-0.1 parts of recombinant fibronectin, and 0.01-0.1 parts of recombinant type XVII collagen by weight.

6. Use of the composition according to any one of claims 1 to 5 in the preparation of cosmetic raw materials or cosmetics.

7. The use according to claim 6, characterized in that: The cosmetic raw material or cosmetic is an aqueous solution, emulsion, spray, cream, gel or facial mask, the mass percentage of the composition in the cosmetic raw material or cosmetic is 0.0001-1%, and the cosmetic raw material or cosmetic further comprises an excipient.

8. The use according to claim 7, characterized in that: The excipient is a liquid excipient or a solid excipient.

9. A repair patch, characterized in that: Its recipe is as follows: 。 10. The method for preparing a repair patch according to claim 9, characterized in that: The specific steps are as follows: (1) According to the formula, mix the moisturizer, thickener, and the composition with repair and anti-aging effects and add deionized water, and stir in a water bath at 80±5℃ until the materials are completely dissolved; (2) After cooling to room temperature, add a pH adjuster to adjust the pH to 6.0-8.0; (3) Fold the membrane cloth and put it into an aluminum foil flat bag, fill the solution obtained in step (2) into the aluminum foil bag, and heat seal it; (4) The aluminum foil bag was sterilized by wet heat sterilization at 110°C for 30 min to obtain a repair patch.